Retina specialists are shifting from povidone iodine to chlorhexidine to prevent infections after eye injections. A new study says either approach is effective. Medscape Medical News
Uncategorized
FDA approves Eydenzelt as biosimilar referencing Eylea
Editor’s note: This is a developing news story. Please check back soon for updates.The FDA approved Eydenzelt, a biosimilar referencing Eylea, for the treatment of four retinal diseases, according to a press release from Celltrion.These conditions incl…
Uncategorized
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood,…
Uncategorized
Study to focus on atropine drops to delay myopia onset
BOSTON — A study of atropine eye drops to delay the onset of pediatric myopia has received federal grants totaling $25 million and will be conducted by researchers at the University of Houston and The Ohio State University.“A study like this has never …
Uncategorized
How can AI and oculomics improve care within communities?
AI paired with the technological advances of automated and robotic fundus cameras will be a catalyst for change.These technologies hold the potential to take specialist-level eye screening into primary care, pharmacies and preclinical spaces, reaching …
Tilak Healthcare Obtains Reimbursement for Odysight®, the First Remote Monitoring Solution in Ophthalmology, via the PECAN Progam
PARIS–(BUSINESS WIRE)–Tilak Healthcare, a pioneering company and leader in digital health for chronic eye disease monitoring, announces that it has received a positive opinion from the French National Health Authority (HAS) for the exceptional reimbu…